Wells Fargo lowered the firm’s price target on DuPont to $75 from $85 and keeps an Overweight rating on the shares. The firm remains bullish on DuPont thanks to its strong balance sheet, stability in W&P, exposure to a recovery in China, and attractive valuation, with further upside from the acquisition of a high-quality healthcare name.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on DD: